Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Morgan Stanley attributes a recent deceleration in Mounjaro sales in Brazil to supply constraints rather than weaker demand. Retailers consistently reported limited inventory even as patient interest remained strong. Weak U.S. GLP-1 imports in December and January may have constrained available product, with a sharp rebound in February imports offe…
Shares of Syntec Optics (NASDAQ:OPTX) climbed 18% after the company announced defense purchase orders exceeding $4 million for optics and opto-mechanical assemblies across multiple U.S. military platforms. The orders cover laser guidance for precision missiles, surveillance and targeting systems, night-vision equipment, specialized defense lasers, …
Shares of Olema Pharmaceuticals (NASDAQ:OLMA) tumbled 41% on Monday after Roche disclosed that its Phase 3 persevERA study failed to achieve a statistically significant improvement in progression-free survival for giredestrant plus palbociclib versus an aromatase inhibitor plus palbociclib. Roche said a numerical improvement was observed but it did…
Piper Sandler analyst Derek Podhaizer says U.S. oilfield services stocks failed to follow a near 40% surge in WTI crude, leaving them vulnerable to a rapid downward correction if the geopolitical conflict eases. Middle East-exposed firms were hit harder, while U.S. land names showed muted gains amid prior strong positioning and doubts about a quick…
Macquarie removed MakeMyTrip (NASDAQ:MMYT) from its Asia Marquee list after the stock fell 25% since being added on December 8, 2025. The broker highlighted an approximately 80% surge in jet fuel spot prices versus the December-quarter average and said geopolitical dynamics are pressuring international travel flows, which weigh on the company’s hig…
Canada's main index futures fell on Monday as intensifying hostilities in the Middle East pushed crude prices sharply higher and unsettled investors. Commodities-heavy S&P/TSX 60 futures lost ground by early trade, while U.S. equity futures plunged as oil surged above $100 a barrel and worries grew that a renewed energy shock could stoke inflation …
Bank of America says a recent hardening in Iran's leadership and the effective closure of the Strait of Hormuz have driven a swift tightening in oil and LNG supplies, lifting front-month Brent above $105 per barrel and TTF gas above e260 per megawatt-hour. The bank reports operational suspensions across several Gulf producers and expects roughly 30…
NATO forces intercepted a ballistic missile fired from Iran toward Turkish territory on Monday, the Defense Ministry said. The intercepted munition produced debris that landed in Gaziantep province, located within several hundred kilometers of major NATO and U.S. facilities in Turkey. The action follows a similar interception on March 4, after whic…
Bank of America on Monday flagged several optical networking companies as likely beneficiaries of sustained demand from data centers combined with tight supply dynamics. The bank identified firms with technical strengths in key components and materials as positioned to capture share amid an industry shift from 800G to 1.6T technology and extended c…
Oracle has publicly rejected recent reports that expansion plans at its Abilene, Texas AI data center were abandoned or troubled, stating that the campus remains on schedule, two buildings are fully operational, and the company has secured the full 4.5 gigawatts of additional capacity it pledged to OpenAI. The clarification arrives amid mixed marke…
Turkey announced the deployment of six F-16 fighter jets and air defence systems to the Turkish Republic of Northern Cyprus, framing the move as a protective measure for the Turkish Cypriot community amid the U.S.-Israeli war against Iran. Ankara said it would take additional steps if required. The deployments follow a recent drone strike on Britai…
Morgan Stanley assesses that Brunello Cucinelli's U.S. revenue will only be modestly affected by additional Saks Global store closures announced March 6, noting the Italian luxury house has limited exposure concentrated in a handful of Saks Fifth Avenue and Neiman Marcus locations and benefits from clienteling and brand loyalty that should help dis…
The Canadian dollar rose Monday morning as global oil benchmarks moved above $100 per barrel after several countries announced additional production cuts amid a near blockage of the Strait of Hormuz. The USD/CAD pair declined 0.3% to 1.3534 by 7:48 a.m. Toronto time, setting the stage for its lowest close since February 11, 2026. Market commentary …
XPeng (NYSE:XPEV) stock rose after Morgan Stanley analysts reported favorable impressions from a hands-on 28-kilometer test of the automaker's VLA 2.0 autonomous driving system in Guangzhou. The brokerage highlighted smoother, more human-like control and said the immediate challenge is converting improved AD tech into broader consumer adoption and …
Walbi has launched a no-code environment that lets retail crypto traders create, test, and deploy AI-driven trading agents without programming. Agents draw on portfolio data, technical indicators, macro signals and liquidation metrics, and were trialed in a 14-week closed beta with over 1,000 participants who created more than 9,500 agents and gene…
Gold.com (GOLD) offers an actionable long after a pullback into the $48-$52 area. Strong free cash flow, a sub-$2B market cap, and a sector rotation toward miners and bullion provides a clear catalyst path. This trade targets a run back to the 52-week high while keeping risk defined below the recent swing low.
uniQure shares climbed 36% after reports that Vinay Prasad, head of the FDA’s division of vaccines and gene therapies, will leave the agency next month to return to academia. The move triggered analyst upgrades for uniQure and broader rallies among gene therapy and rare disease stocks, with REGENXBIO up 13% and Biohaven rising 23%. Several analysts…
Altimmune President and CEO Jerome Benedict Durso acquired 20,000 shares of the company on March 6, 2026, paying a weighted average of $3.5395 per share for a total of $70,790. The purchase occurred while the stock traded near $3.54 after a 15% decline over the prior week. The company recently reported fourth-quarter 2025 results that missed expect…
Indonesia's Communications and Digital Ministry has distributed a ministerial regulation that directs platforms to deactivate social media accounts deemed 'high risk' for users under 16, effective March 28. Platforms named by the ministry include Roblox, Instagram, YouTube and TikTok. Company spokespeople said they are reviewing the rule and engagi…
The British pound has strengthened against the dollar over the past month despite domestic economic challenges, with Bank of America attributing the move to shifts in terms of trade, portfolio positioning and energy-sector flows rather than a sudden improvement in underlying fundamentals. Analysts note a break in the historical relationship between…
UBS warns that a sharp jump in energy costs following the Iran war has created simultaneous upward pressure on inflation and a drag on growth, complicating the European Central Bank's policy path. Markets have repriced expectations toward cumulative rate increases by December 2026, and UBS expects the ECB to present multiple scenarios at its March …
Markets have sharply repriced expectations for central bank policy after the Iran war elevated oil prices and the risk of sustained supply disruption. Investors now see the European Central Bank, the Swiss National Bank and Sweden's Riksbank moving to raise rates this year, with the Bank of England pushed back into the tightening conversation for 2…
Xenon Pharmaceuticals shares climbed 40% after topline results from the Phase 3 X-TOLE2 trial showed azetukalner significantly reduced focal onset seizure frequency versus placebo, meeting both primary and key secondary endpoints in two dose groups. The company plans to submit a New Drug Application in the third quarter of 2026.
U.S. stock futures fell sharply Monday after escalation in the Middle East conflict pushed energy prices higher, stoking worries about future economic growth. In premarket action a range of companies moved decisively: Hims & Hers and several smaller biotech and specialty companies jumped, while established drugmakers and life-science suppliers dipp…
Korro Bio Inc. (NASDAQ:KRRO) said on Monday it has secured an oversubscribed $85 million private investment in public equity (PIPE) financing, led by Venrock Healthcare Capital Partners. The financing, which prompted a 17% intraday gain for KRRO shares, will combine with the company's existing cash and marketable securities to extend its cash runwa…
